雲南鍺業(002428.SZ):東昌公司主要從構建光催化分解水制氫——二氧化鍺還原生產的應用系統,驗證光催化分解水制氫純度
格隆匯8月9日丨有投資者向雲南鍺業(002428.SZ)提問,“高效低成本分解水制氫光催化劑及其應用關鍵技術研發項目這次獲得獎勵資金140多萬是比較多的一個,請問公司從事工藝方面研發?技術來自昆明高校?”
雲南鍺業回覆稱,上述項目由公司全資子公司雲南東昌金屬加工有限公司與兩所高校聯合研發,公司子公司東昌公司主要從構建光催化分解水制氫——二氧化鍺還原生產的應用系統,驗證光催化分解水制氫純度,解決應用過程中的關鍵技術,合理降低生產成本方面開展研發。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.